Description
Book SynopsisQuantitative Molecular Pharmacology and Informatics in Drug Discovery Michael Lutz, Section Head, Cheminformatics Group and Terry Kenakin, Principal Research Scientist, Glaxo Wellcome Research and Development, Research Triangle Park, NC, USA Quantitative Molecular Pharmacology and Informatics in Drug Discovery combines pharmacology, genetics and statistics to provide a complete guide to the modern drug discovery process. The book discusses the pharmacology of drug testing and provides a detailed description of the statistical methods used to analyze the resulting data. Application of genetic and genomic tools for identification of biological targets is reviewed in the context of drug discovery projects. Covering both the theoretical principles upon which the techniques are based and the practicalities of drug discovery, this informative guide.
* outlines in step-by-step detail the advantages and disadvantages of each technology and approach and links these to the type of chemical
Trade Review"...a timely and important book..." "I recommend this book to pharmaceutical company statisticians..."
--Biometrics, September 2000
"...covers a tremendous amount of ground....I recommend this book to pharmaceutical statisticians..."
--Technometrics, 2000
Table of ContentsDrug Discovery.
Measurement of Drug Affinity.
Efficacy.
Pharmacological Assays Used in Screening for Therapeutic Ligands.
Finding the Optimal Assay Format for the Chemical Target.
Mathematical and Statistical Framework for Problems in Drug Discovery.
Statistical Methods for Target Identification and Validation.
Experimental Design.
Analysis and Interpretation of Data.
Index.
